middle.news
How Holista’s $9M Collagen Deal with Regenerex Could Transform Wound Care
12:42am on Sunday 21st of December, 2025 AEDT
•
Healthcare
Read Story
How Holista’s $9M Collagen Deal with Regenerex Could Transform Wound Care
12:42am on Sunday 21st of December, 2025 AEDT
Key Points
Exclusive worldwide rights granted to Regenerex for Holista’s collagen in wound care
Minimum purchase commitments escalating from USD 50,000 in 2025 to USD 9 million annually from 2028
Regenerex to fund clinical trials and regulatory approvals including FDA processes
Joint innovation on nano-collagen applications with shared intellectual property
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Holista Colltech (ASX:HCT)
OPEN ARTICLE